Claymore Investments (Mauritius) Pte. Ltd. has acquired a significant stake in Dr. Agarwal’s Health Care Limited. The transaction, involving 6,35,71,770 shares before the sale and resulting in a holding of 4,76,71,770 shares post-acquisition, represents 20.06% and 15.04% of the total voting capital respectively. This substantial change in shareholding, crossing a 2% threshold on August 12, 2026, impacts the control and voting rights within the target company.
Shareholding Changes in Dr. Agarwal’s Health Care
Claymore Investments (Mauritius) Pte. Ltd., along with its Persons Acting in Concert (PACs), has disclosed a substantial shift in their shareholding in Dr. Agarwal’s Health Care Limited. The disclosure indicates a significant acquisition of shares, altering the ownership landscape of the company. The transaction involved the purchase of shares on the open market, as detailed in the disclosures filed with the stock exchanges.
Transaction Details
Prior to the sale, the seller and its PACs held a total of 6,35,71,770 shares, representing 20.06% of the total share capital. Following the acquisition, their combined holding stands at 4,76,71,770 shares, equating to 15.04% of the total share capital. The 2% limit was crossed on August 12, 2026, marking a key date for this substantial acquisition. The shares acquired were primarily voting rights carrying shares, with no significant encumbrances or other convertible instruments involved in this specific transaction.
Target Company and Seller Information
Dr. Agarwal’s Health Care Limited is the Target Company (TC). The seller in this transaction is Claymore Investments (Mauritius) Pte. Ltd., and Arvon Investments Pte. Ltd. is identified as a PAC. Neither the seller nor its PACs are part of the Promoter/Promoter group of Dr. Agarwal’s Health Care Limited. The shares were traded on the BSE Limited and the National Stock Exchange of India Limited.
Capital Structure
Before the acquisition, the total equity share capital of Dr. Agarwal’s Health Care Limited was INR 31,69,83,028, comprising 31,69,83,028 equity shares of face value INR 1/- each. Post-acquisition, the total diluted share/voting capital stands at INR 31,92,62,876, comprising 31,92,62,876 equity shares. The disclosures note that all percentage shareholdings have been rounded to two decimal places.
Source: BSE
